Value through Innovation27 July 2016

Clinical Study Results

  • LAXOBERAL ® - Healthy
    Clinical Study Number 122.57
    Study Indication Healthy
    Product LAXOBERAL ®
    Generic Name Bisacodyl
    Lab Code
    Clinical Phase I
    Study Title

    Investigation of the pharmacokinetics of 10 mg bisacodyl (coated tablets) or 10 mg sodium picosulfate (drops) administered orally in healthy lactating females.

    Study Document Trial synopsis 122.57_CO english
  • LAXOBERAL ® - Constipation
    Clinical Study Number 1062.7
    Study Indication Constipation
    Product LAXOBERAL ®
    Generic Name Sodium picosulfate
    Lab Code
    Clinical Phase IIIb
    Study Title

    A randomised, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of 4 weeks treatment with sodium picosulfate [Dulcolax®, Laxoberal®] drops 10 mg administered orally, once daily, in patients with functional constipation

    Study Document Trial synopsis 1062.7_DR english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.